TRENTON, N.J. — A federal judge has dismissed a large part of the multidistrict litigation over claims that Pfizer Inc. schemed to keep generic Lipitor off the market.
The ruling by U.S. District Judge Peter Sheridan on September 5 stemmed from a motion to dismiss the claims brought by direct purchasers, including Walgreens Co., Safeway Inc., The Kroger Co. and Value Drug Co.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
